Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|SNSS||Sunesis Pharmaceuticals, Inc.||-5.63%||7.55||0.7%||$527.77m|
|REGN||Regeneron Pharmaceuticals, Inc.||-0.58%||499.69||2.7%||$447.00m|
|GILD||Gilead Sciences, Inc.||-1.38%||65.95||1.0%||$437.06m|
|VRTX||Vertex Pharmaceuticals, Inc.||-0.10%||219.18||1.9%||$383.57m|
|ALXN||Alexion Pharmaceuticals, Inc.||1.09%||165.47||2.0%||$360.29m|
|NBIX||Neurocrine Biosciences, Inc.||-1.79%||94.85||4.9%||$180.78m|
|EXAS||EXACT Sciences Corp.||-1.93%||127.53||18.4%||$168.47m|
|CRSP||CRISPR Therapeutics AG||-2.97%||115.04||0.6%||$158.56m|
Zai Lab Ltd. is a biopharmaceutical company. It engages in the discovering, licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need in the fields of oncology, infectious, and autoimmune diseases. The firm's products include Zejula and Optune. The company was founded by Samantha Ying Du and Marietta Wu in April 2014 and is headquartered in Shanghai, China.